Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC004 capsules in NTRK gene fusion-positive solid tumors (China, phase III)
CTR20244050Phase 3Active
- Sponsor
- Wecare Probiotics
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eratrectinib in Nonhematologic neoplasms, sponsored by Wecare Probiotics. Started Mar 2025; status: active.
02
Drugs
eratrectinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20244050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244050.